Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTISS in DIEP/MS-TRAM breast reconstruction
NCT04931615Phase 4Completed
- Sponsor
- Mid and South Essex NHS Foundation Trust
- Start
- Feb 2022
- Primary completion
- Feb 2023
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of porcine fibrin sealant in breast cancer (2 arms), sponsored by Mid and South Essex NHS Foundation Trust. Primary endpoint: post-operative abdominal mean drainage duration at 42 days. Started Feb 2022; status: completed.
02
Drugs
porcine fibrin sealant
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04931615.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04931615.